Showing results (41-50 of 404) with videos related to

Sort By:
Pageof 41
Anti-Cancer Drugs|May 30, 2014
A systematic review of raltitrexed-based first-line chemotherapy in advanced colorectal cancerSandro Barni, Antonio Ghidini, Andrea Coinu, et al.
International Journal of Colorectal Disease|February 3, 2011
Cetuximab and panitumumab in KRAS wild-type colorectal cancer: a meta-analysisFausto Petrelli, Karen Borgonovo, Mary Cabiddu, et al.
Expert Review of Anticancer Therapy|October 16, 2009
Is there a role for maintenance therapy in non-small-cell lung cancer? An emerging issueFausto Petrelli, Mara Ghilardi, Marco Cremonesi, et al.
Journal of Cancer Research and Clinical Oncology|October 6, 2011
Addition of iron to erythropoiesis-stimulating agents in cancer patients: a meta-analysis of randomized trialsFausto Petrelli, Karen Borgonovo, Mary Cabiddu, et al.
Reviews on Recent Clinical Trials|August 19, 2015
Prognostic factors after R0 resection of colorectal cancer liver metastases: A systematic review and pooled-analysisFausto Petrelli, Andrea Coinu, Alberto Zaniboni, et al.
Breast Cancer Research and Treatment|June 13, 2012
Mortality, leukemic risk, and cardiovascular toxicity of adjuvant anthracycline and taxane chemotherapy in breast cancer: a meta-analysisFausto Petrelli, Karen Borgonovo, Mary Cabiddu, et al.
Anti-Cancer Drugs|January 11, 2011
Neoadjuvant chemotherapy and concomitant trastuzumab in breast cancer: a pooled analysis of two randomized trialsFausto Petrelli, Karen Borgonovo, Mary Cabiddu, et al.
Nature Reviews. Urology|October 13, 2010
Progression of intramedullary metastasis during perioperative cessation of sunitinibFausto Petrelli, Mary Cabiddu, Marinella Carpo, et al.
Anti-Cancer Drugs|October 18, 2016
Modified schedules of DCF chemotherapy for advanced gastric cancer: a systematic review of efficacy and toxicityFausto Petrelli, Gianluca Tomasello, Michele Ghidini, et al.
Reviews on Recent Clinical Trials|March 9, 2010
What else in gemcitabine-pretreated advanced pancreatic cancer? An update of second line therapiesFausto Petrelli, Karen Borgonovo, Mara Ghilardi, et al.
Pageof 41